Cargando…
Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular events
BACKGROUND: Sphingolipids are a family of circulating lipids with regulatory and signaling roles that are strongly associated with both eGFR and cardiovascular disease. Patients with chronic kidney disease (CKD) are at high risk for cardiovascular events, and have different plasma concentrations of...
Autores principales: | Lidgard, Benjamin, Bansal, Nisha, Zelnick, Leila R., Hoofnagle, Andrew N., Fretts, Amanda M., Longstreth, William T., Shlipak, Michael G., Siscovick, David S., Umans, Jason G., Lemaitre, Rozenn N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474367/ https://www.ncbi.nlm.nih.gov/pubmed/37634384 http://dx.doi.org/10.1016/j.ebiom.2023.104765 |
Ejemplares similares
-
High-Density Lipoprotein Lipidomics and Mortality in CKD
por: Lidgard, Benjamin, et al.
Publicado: (2023) -
Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018) -
Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study
por: Gharib, Arya R., et al.
Publicado: (2023) -
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018) -
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
por: Jensen, Paul N., et al.
Publicado: (2022)